Target Preclinical Phase 1 Phase 2 Phase 3
Clinical   Solid Tumors & Hem Malignancies (Adults)
Trial 1801 – – Phase 1 / 2
  Pancreatic Cancer (1st Line Treatment)
Trial 1801 – Phase 2
 Myelofibrosis
Trial 1901 – Phase 2
 Solid Tumors (Pediatrics)
Trial 1902 – Phase 1
 Neuroblastoma
Trial 2001 – Phase 2
 Fibrotic Diseases
Candidate Screening
CMC  Oral Formulation
Development/Testing